EGEN (Pharmaceuticals) Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $44.4M

EGEN (Pharmaceuticals) General Information

Description

Provider of therapeutic nucleic acids and proteins for specific diseases. The company specializes in Deoxyribo Nucleic Acid (DNA) and Ribonucleic Acid Interference (RNAi) delivery and therapeutics for the treatment of human diseases including cancer and cardiovascular disease.

Contact Information

Website
www.egeninc.com
Formerly Known As
Expression Genetics
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 601 Genome Way Northwest
  • Suite 3100
  • Huntsville, AL 35806
  • United States
+1 (256)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Imunon
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 601 Genome Way Northwest
  • Suite 3100
  • Huntsville, AL 35806
  • United States
+1 (256)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EGEN (Pharmaceuticals) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 20-Jun-2014 $44.4M Completed Clinical Trials - General
5. Later Stage VC 17-Dec-2012 Completed Generating Revenue
4. Later Stage VC 18-Sep-2012 Completed Generating Revenue
3. Later Stage VC (Series B) 04-Aug-2008 Completed Generating Revenue
2. Grant 30-Oct-2007 $164K Completed Startup
1. Grant 01-Jan-2007 $1M Completed Startup
To view EGEN (Pharmaceuticals)’s complete valuation and funding history, request access »

EGEN (Pharmaceuticals) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of therapeutic nucleic acids and proteins for specific diseases. The company specializes in Deoxyribo Nucleic A
Drug Discovery
Huntsville, AL

Plymouth Meeting, PA
 

Arlington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

EGEN (Pharmaceuticals) Competitors (78)

One of EGEN (Pharmaceuticals)’s 78 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Kala Bio Formerly VC-backed Arlington, MA
Cogent Biosciences Formerly VC-backed Waltham, MA
Solid Biosciences Formerly VC-backed Charlestown, MA
Sorrento Therapeutics Formerly VC-backed San Diego, CA
You’re viewing 5 of 78 competitors. Get the full list »

EGEN (Pharmaceuticals) Patents

  • 52

    Total Documents Applications and Grants

  • Total Patents Families

  • 12

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

EGEN (Pharmaceuticals) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2015163687-A1 Method and apparatus for deciding omission of sales related to battery charge or rental service Inactive 23-Apr-2014
WO-2014181993-A1 Battery module for vehicle equipment and method for driving same Inactive 08-May-2013
AU-2012358181-A1 Compositions and methods for the delivery of biologically active rnas Inactive 23-Dec-2011
AU-2012358181-A8 Compositions and methods for the delivery of biologically active rnas Inactive 23-Dec-2011
CA-2860228-A1 Compositions and methods for the delivery of biologically active rnas Inactive 23-Dec-2011 C12N15/111
To view EGEN (Pharmaceuticals)’s complete patent history, request access »

EGEN (Pharmaceuticals) Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Greer Capital Advisors Venture Capital Minority
To view EGEN (Pharmaceuticals)’s complete investors history, request access »

Ready to get started?

Request a free trial

EGEN (Pharmaceuticals) FAQs

  • When was EGEN (Pharmaceuticals) founded?

    EGEN (Pharmaceuticals) was founded in 2002.

  • Where is EGEN (Pharmaceuticals) headquartered?

    EGEN (Pharmaceuticals) is headquartered in Huntsville, AL.

  • What industry is EGEN (Pharmaceuticals) in?

    EGEN (Pharmaceuticals)’s primary industry is Drug Discovery.

  • Is EGEN (Pharmaceuticals) a private or public company?

    EGEN (Pharmaceuticals) is a Private company.

  • What is the current valuation of EGEN (Pharmaceuticals)?

    The current valuation of EGEN (Pharmaceuticals) is .

  • What is EGEN (Pharmaceuticals)’s current revenue?

    The current revenue for EGEN (Pharmaceuticals) is .

  • How much funding has EGEN (Pharmaceuticals) raised over time?

    EGEN (Pharmaceuticals) has raised $23.4M.

  • Who are EGEN (Pharmaceuticals)’s investors?

    Greer Capital Advisors has invested in EGEN (Pharmaceuticals).

  • Who are EGEN (Pharmaceuticals)’s competitors?

    Inovio Pharmaceuticals, Kala Bio, Cogent Biosciences, Solid Biosciences, and Sorrento Therapeutics are some of the 78 competitors of EGEN (Pharmaceuticals).

  • When was EGEN (Pharmaceuticals) acquired?

    EGEN (Pharmaceuticals) was acquired on 20-Jun-2014.

  • Who acquired EGEN (Pharmaceuticals)?

    EGEN (Pharmaceuticals) was acquired by Imunon.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process